Slash Boxes

SoylentNews is people

posted by martyb on Wednesday February 13 2019, @08:06AM   Printer-friendly
from the know-when-to-hold-'em,-know-when-to-fold-'em dept.

Making New Drugs With a Dose of Artificial Intelligence

Every two years, hundreds of scientists enter a global competition. Tackling a biological puzzle they call "the protein folding problem," they try to predict the three-dimensional shape of proteins in the human body. No one knows how to solve the problem. Even the winners only chip away at it. But a solution could streamline the way scientists create new medicines and fight disease.

Mohammed AlQuraishi, a biologist who has dedicated his career to this kind of research, flew in early December to Cancun, Mexico, where academics were gathering to discuss the results of the latest contest. As he checked into his hotel, a five-star resort on the Caribbean, he was consumed by melancholy. The contest, the Critical Assessment of Structure Prediction, was not won by academics. It was won by DeepMind, the artificial intelligence lab owned by Google's parent company. "I was surprised and deflated," said Dr. AlQuraishi, a researcher at Harvard Medical School. "They were way out in front of everyone else."

[...] "It is not that machines are going to replace chemists," said Derek Lowe, a longtime drug discovery researcher and the author of In the Pipeline, a widely read blog dedicated to drug discovery. "It's that the chemists who use machines will replace those that don't."

After the conference in Cancun, Dr. AlQuraishi described his experience in a blog post. The melancholy he felt after losing to DeepMind gave way to what he called "a more rational assessment of the value of scientific progress." But he strongly criticized big pharmaceutical companies like Merck and Novartis, as well as his academic community, for not keeping pace.

[For those who might not be aware, the Derek Lowe mentioned above is the author of the Things I Won't Work With blog. If you want to read about things that burn, go BOOM, or otherwise wreak havoc you'd be hard pressed to find a more entertaining source. --martyb]

Original Submission

Related Stories

In The Pipeline: Coronavirus 45 comments

As the world knows, we face an emerging virus threat in the Wuhan coronavirus (2019-nCoV) outbreak. The problem is, right now there are several important things that we don't know about the situation. The mortality rate, the ease of human-human transmission, the rate of mutation of the virus (and how many strains we might be dealing with – all of these need more clarity. Unfortunately, we've already gone past the MERS outbreak in severity (which until now was the most recent new coronavirus to make the jump into humans). If we're fortunate, though, we'll still have something that will be worrisome, but not as bad as (say) the usual flu numbers (many people don't realize that influenza kills tens of thousands of people in the US each year). The worst case, though, is something like 1918, and we really, really don't need that.

[Ed note: The linked story is by Derek Lowe who writes a "commentary on drug discovery and the pharma industry". He is perhaps best known for his "Things I Won't Work With" blog entries which are as hilarious as they are... eye opening. I have found him to be a no-nonsense writer who "tells things as they are", holding no punches. The whole story is worth reading as he clearly explains what a coronavirus is, about the current one that reportedly originated in Wuhan, China, what could be done about it, how long that would likely take, and what can be done for those who have already been infected. --martyb]

Previous Stories Referencing Derek Lowe:

Original Submission

This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2) by opinionated_science on Wednesday February 13 2019, @12:03PM

    by opinionated_science (4031) on Wednesday February 13 2019, @12:03PM (#800565)

    All these algorithms are brute force - with constraints from existing protein structures (xray, nmr, etc).

    "Deepmind" is a marketing division of Google to buy their stuff - impressive they pointed it at the problem - not sure how much it helps.

    "deepmind" is *really* useful if you have a mountain of classified (i.e. pre tagged) data, but worthless in telling you *how* to classify.

  • (Score: 2) by Spamalope on Wednesday February 13 2019, @02:25PM (1 child)

    by Spamalope (5233) on Wednesday February 13 2019, @02:25PM (#800591) Homepage

    If you want to read about things that burn, go BOOM
    Definitely read the FOOF post, along with some of the comments.

    • (Score: 0) by Anonymous Coward on Wednesday February 13 2019, @03:01PM

      by Anonymous Coward on Wednesday February 13 2019, @03:01PM (#800603)

      It's amazing how easy it is to kill a living creature with some molecules.

  • (Score: 2) by hendrikboom on Thursday February 14 2019, @09:37PM

    by hendrikboom (1125) Subscriber Badge on Thursday February 14 2019, @09:37PM (#801227) Homepage Journal

    It is already known that folding doesn't depend on the base sequence alone. There are other chemicals, called "chaperones" that affect how a protein will fold.

    Pure brute-force chemical-bond computation will have to calculate the effects of the (unknown) chaperones on the folding process.

    So what was the AI trained on? Known proteins and the way they folded? Those training data will already contain the consequences of the (unknown) chaperones. This is an advantage. It enables the AI to guess straight through to the result without yielding any insight into the process.

    -- hendrik